Quality of care measures for migraine: A comprehensive review

Disease Management

Volumn 10, Issue 3, 2007, Pages 138-146

  Gagne, Joshua J ^a,b   Leas, Brian ^a   Lofland, Jennifer H ^a   Goldfarb, Neil ^a   Freitag, Frederick ^c   Silberstein, Stephen ^d  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^c DIAMOND HEADACHE CLINIC   (United States)

^d THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORPROMAZINE; CYPROHEPTADINE; DIHYDROERGOTAMINE; ERGOTAMINE; FENOPROFEN; FLUOXETINE; KETOROLAC; METOCLOPRAMIDE; NAPROXEN; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE AGONIST; PARACETAMOL; PLACEBO; PROPRANOLOL DERIVATIVE; SUMATRIPTAN; TIMOLOL; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID;

ARTICLE; CLINICAL INDICATOR; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DISABILITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; EVIDENCE BASED MEDICINE; FUNCTIONAL ASSESSMENT; HEADACHE; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; MIGRAINE; PRACTICE GUIDELINE; PROPHYLAXIS; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SELF REPORT; TENSION HEADACHE; UNSPECIFIED SIDE EFFECT;

DISEASE MANAGEMENT; HUMANS; MIGRAINE DISORDERS; PRACTICE GUIDELINES; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE; UNITED STATES;

EID: 34548602013     PISSN: 1093507X     EISSN: None     Source Type: Journal    
DOI: 10.1089/dis.2007.103639     Document Type: Article

References (51)

1. Linet MS, Stewart WF, Celentano DD, Ziegler D, Sprecher M. An epidemiologic study of headache among adolescents and young adults. JAMA. 1989; 261:2211-2216.
2. Diamond S, Silberstein S, Loder E, Reed ML, Bigal ME, Lipton RB. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: Results from the American Migraine Prevalence and Prevention (AMPP) study. Cephalgia. In press.
3. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992;267:64-69.
4. Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF. Migraine in the United States: Epidemiology and patterns of health care use. Neurology. 2002;58:885-894.
5. Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the united states: Disability and economic costs. Arch Intern Med. 1999;159:813-818.
6. Hawkins K, Rupnow M, Wang S. Direct cost burden of migraine among members of US employers. Poster presented at: Annual Meeting of the American Headache Society; June 2006; Los Angeles, CA.
7. Osterhaus JT, Gutterman DL, Plachetka JR. Health care resource and lost labour costs of migraine headache in the US. Pharmacoeconomics. 1992;2:67-76.
8. Hawkins K, Wang S, Rupnow M. Indirect cost burden of migraine among several large US employers. Poster presented at: Annual Meeting of the American Headache Society; June 2006; Los Angeles, CA.
9. Solomon GD, Price KL. Burden of migraine. A review of its socioeconomic impact. Pharmacoeconomics. 1997; 11(suppl 1):1-10.
10. Solomon GD, Litaker DG. The impact of drug therapy on quality of life in headache and migraine. Pharmacoeconomics. 1997;11:334-342.
11. Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: A Canadian population survey. Can J Neurol Sci. 1993;20:131-137.
12. Michel P, Dartigues JF, Duru G, Moreau J, Salamon R, Henry P. Incremental absenteeism due to headaches in migraine: Results from the MIG-access French national cohort. Cephalalgia. 1999;19:503-510.
13. Goetzel RZ, Long SR, Ozminkowski RJ, Hawkins K, Wang S, Lynch W. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. J Occup Environ Med. 2004;46:398-412.
14. National Committee for Quality Assurance. HEDIS 2006. Washington, DC: National Committee for Quality Assurance; 2006.
15. National Quality Forum. Available at: 〈www.quality forum.org〉. Accessed April 10, 2007.
16. Ambulatory Care Quality Alliance. Available at: 〈www.aqaalliance. org〉. Accessed April 10, 2007.
17. Lipton RB, Silberstein SD, Stewart WF. An update on the epidemiology of migraine. Headache. 1994;34:319-328.
18. Warshaw LJ, Burton WN. Cutting the costs of migraine: Role of the employee health unit. J Occup Environ Med. 1998;40:943-953.
19. Warshaw LJ, Burton WN, Schneider WJ. Role of the workplace in migraine disease management. Dis Manage Health Outcomes. 2001;9:99-115.
20. Campinha-Bacote DL, Kendle JB, Jones C, et al. Impact of a migraine management program on improving health outcomes. Dis Manage. 2005;8:382-391.
21. Hu HX, Solomon GD, Conboy K, Demi L, Markson LE. Impact of a migraine disease management program: Humanistic outcomes. Dis Manage Health Outcomes. 2004;12:273-280.
22. Silberstein SD, Rosenberg J. Multispecialty consensus on diagnosis and treatment of headache. Neurology. 2000;54:1553.
23. st Century. Washington, DC: National Academies Press; 2001.
24. Donabedian A. The quality of care. How can it be assessed? JAMA. 1988;260:1743-1748.
25. Perrin EB. Some thoughts on outcomes research, quality improvement, and performance measurement. Med Care. 2002 Jun;40(6 suppl):III89-III91.
26. Hartmaier SL, Santanello NC, Epstein RS, Silberstein SD. Development of a brief 24-hour migraine-specific quality of life questionnaire. Headache. 1995;35:320-329.
27. Santanello NC, Hartmaier SL, Epstein RS, Silberstein SD. Validation of a new quality of life questionnaire for acute migraine headache. Headache. 1995;35:330-337.
28. Wagner TH, Patrick DL, Galer BS, Berzon RA. A new instrument to assess the long-term quality of life effects from migraine: Development and psychometric testing of the MSQOL. Headache. 1996;36:484-492.
29. Jhingran P, Davis SM, LaVange LM, Miller DW, Helms RW. MSQ: Migraine-specific quality-of-life questionnaire. Further investigation of the factor structure. Pharmacoeconomics. 1998;13:707-717.
30. Jhingran P, Osterhaus JT, Miller DW, Lee JT, Kirchdoerfer L. Development and validation of the migraine-specific quality of life questionnaire. Headache. 1998;38:295-302.
31. Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J. Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia. 1999;19:107-114;discussion 74.
32. Stewart WF, Lipton RB, Whyte J, et al. An international study to assess reliability of the migraine disability assessment (MIDAS) score. Neurology. 1999;53: 988-994.
33. Jacobson GP, Ramadan NM, Aggarwal SK, Newman CW. The Henry Ford hospital headache disability inventory (HDI). Neurology. 1994;44:837-842.
34. Jacobson GP, Ramadan NM, Norris L, Newman CW. Headache disability inventory (HDI): Short-term test-retest reliability and spouse perceptions. Headache. 1995;35:534-539.
35. Stewart WF, Lipton RB, Simon D, Liberman J, Von Korff M. Validity of an illness severity measure for headache in a population sample of migraine sufferers. Pain. 1999;79:291-301.
36. Stewart WF, Lipton RB, Simon D, Von Korff M, Liberman J. Reliability of an illness severity measure for headache in a population sample of migraine sufferers. Cephalalgia. 1998;18:44-51.
37. Bjorner JB, Kosinski M, Ware JE, Jr. Using item response theory to calibrate the headache impact test (HIT) to the metric of traditional headache scales. Qual Life Res. 2003;12:981-1002.
38. Kosinski M, Bayliss MS, Bjorner JB, et al. A six-item short-form survey for measuring headache impact: The HIT-6. Qual Life Res. 2003;12:963-974.
39. Bjorner JB, Kosinski M, Ware JE, Jr. Calibration of an item pool for assessing the burden of headaches: An application of item response theory to the headache impact test (HIT). Qual Life Res. 2003;12:913-933.
40. Chatterton ML, Lofland JH, Shechter A, et al. Reliability and validity of the migraine therapy assessment questionnaire. Headache. 2002;42:1006-1015.
41. Dowson AJ, D'Amico D, Tepper SJ, Baos V, Baudet F, Kilminster S. Identifying patients who require a change in their current acute migraine treatment: The migraine assessment of current therapy (migraine-ACT) questionnaire. Neurol Sci. 2004;25 (suppl 3): S276-S278.
42. Institute of Clinical Systems Improvement. Health Care Guideline: Diagnosis and treatment of headache. Available at: 〈www.icsi.org/ guidelines_and_more/ guidelines_order_sets_protocols/other_health_ care_conditions/headache/headache_diagnosis_ and_treatment_of_guideline_. html〉. Accessed April 10, 2007.
43. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348:2635-2645.
44. Lapuerta P, Asch S. Headache. In: McGlynn EA, Kerr EA, Damberg CL, Asch SM, eds. Quality of Care for Women: A Review of Selected Clinical Conditions and Quality Indicators. Santa Monica, CA: RAND Corporation; 2000.
45. Lapuerta P, Asch S, Clark K. Headache. In: Kerr EA, Asch SM, Hamilton EG, McGlynn EA, eds. Quality of Care for General Medical Conditions: A Review of the Literature and Quality Indicators. Santa Monica, CA: RAND Corporation; 2000.
46. Lipton RB, Stewart WF, Stone AM, Lainez MJ, Sawyer JP. Disability in Strategies of Care Study group. Stratified care vs step care strategies for migraine: The disability in strategies of care (DISC) study: A randomized trial. JAMA. 2000;284:2599-2605.
47. Sculpher M, Millson D, Meddis D, Poole L. Cost-effectiveness analysis of stratified versus stepped care strategies for acute treatment of migraine: The disability in strategies for care (DISC) study. Pharmacoeconomics. 2002;20:91-100.
48. Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with an angiotensin II receptor blocker: A randomized controlled trial. JAMA. 2003;289:65-69.
49. Kaniecki R, Lucas S. Treatment of primary headache: preventive treatment of migraine. In: Standards of Care for Headache Diagnosis and Treatment. Chicago,IL: National Headache Foundation; 2004:40-52.
50. Lipton RB, Dodick D, Sadovsky R, et al. A self-administered screener for migraine in primary care: The ID migraine validation study. Neurology. 2003;61:375-382.
51. Cady RK, Borchert LD, Spalding W, Hart CC, Sheftell FD. Simple and efficient recognition of migraine with 3-question headache screen. Headache. 2004;44:323-327.